神经退行性疾病中的嗅觉功能障碍:是否存在共同的病理基础?
该综述探讨神经退行性疾病中嗅觉功能障碍的严重程度差异是否源于共同原始神经病理底物的差异性破坏。文章指出前脑神经递质与神经调节回路(尤其是胆碱能传递)的损伤程度似乎与多种神经退行性疾病的定量嗅觉测试评分相关,并提出需区分该底物损伤与疾病特异性因素或呼吸感染、污染等对嗅觉感知差异的贡献。
要点
- 神经退行性疾病中嗅觉障碍程度不一,阿尔茨海默病与帕金森病为严重丧失,进行性核上性麻痹相对较轻。
- 前脑神经递质与神经调节回路(尤其胆碱能传递)的损伤程度似与多种神经退行性疾病的定量嗅觉测试评分相关。
- 嗅觉缺陷常早于临床前期出现,明确其基础可能为疾病病理最早阶段提供关键线索。
核心结论
- 神经退行性疾病中嗅觉功能障碍的差异可能源于共同原始神经病理底物的差异性破坏,但尚需区分该底物损伤与疾病特异性因素或呼吸感染、污染等的作用。
研究设计与样本
- 综述性文章,讨论神经退行性疾病中嗅觉功能障碍的病理基础,未报告系统检索范围或样本量。
主要发现
- 阿尔茨海默病与帕金森病可见严重嗅觉丧失,进行性核上性麻痹嗅觉丧失相对较轻。
- 前脑神经递质与神经调节回路(最显著为胆碱能传递)的损伤量与多种神经退行性疾病的定量嗅觉测试评分似相关。
临床怎么用
- 临床评估神经退行性疾病时需注意嗅觉障碍程度因疾病而异,定量嗅觉测试评分或可反映前脑胆碱能等回路损伤程度。
- 嗅觉缺陷常早于临床前期出现,对早期识别与病理机制研究有潜在价值。
局限性
- 原文未报告系统检索策略、纳入研究数量或偏倚评估。
- 共同病理底物与疾病特异性因素、呼吸感染或污染对嗅觉感知差异的相对贡献尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In patients with neurodegenerative diseases, there is a spectrum of smell dysfunction ranging from severe loss, as seen in Alzheimer's disease and Parkinson's disease, to relatively little loss, as seen in progressive supranuclear palsy. Given the ubiquitous but varying degrees of olfactory dysfunction among such diseases, it is conceivable that differential disruption of a common primordial neuropathological substrate causes these differences in olfactory function. For example, the amount of damage to forebrain neurotransmitter and neuromodulator circuits, most notably those involving cholinergic transmission, appears to be correlated with quantitative smell test scores across a wide range of neurodegenerative diseases. Thus, a key question is whether damage to such a substrate is the basis for the perceptual differences in olfaction or whether disease-specific or other entities, such as respiratory infections or pollution, are responsible. In light of the early preclinical onset of smell deficits in many neurodegenerative diseases, the answer to this question might provide crucial insight into the cause of disease pathology at its earliest stages of development.
引用
- Doty RL. Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol. 2017. PMID: 28504111. doi:10.1016/S1474-4422(17)30123-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。